A New Strategy for Healthcare-Associated Pneumonia: A 2-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-Resistant Pathogens to Select Initial Empiric Therapy | Zendy

Takaya Maruyama | Zendy; Takao Fujisawa | Zendy; Mitsuru Okuno | Zendy; H. Toyoshima | Zendy; Kiyoyuki Tsutsui | Zendy; Hiroshi Maeda | Zendy; Hisamichi Yuda | Zendy; M. Yoshida | Zendy; Hirofumi Kobayashi | Zendy; Osamu Taguchi | Zendy; Esteban C. Gabazza | Zendy; Yoshio Takei | Zendy; Naoyuki Miyashita | Zendy; Toshiaki Ihara | Zendy; Vicens Díaz-Brito | Zendy; Michael S. Niederman | Zendy

Open Access

A New Strategy for Healthcare-Associated Pneumonia: A 2-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-Resistant Pathogens to Select Initial Empiric Therapy

Author(s) -

Takaya Maruyama,

Takao Fujisawa,

Mitsuru Okuno,

H. Toyoshima,

Kiyoyuki Tsutsui,

Hiroshi Maeda,

Hisamichi Yuda,

M. Yoshida,

Hirofumi Kobayashi,

Osamu Taguchi,

Esteban C. Gabazza,

Yoshio Takei,

Naoyuki Miyashita,

Toshiaki Ihara,

Vicens Díaz-Brito,

Michael S. Niederman

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit571

Subject(s) - medicine , empiric therapy , pneumonia , odds ratio , prospective cohort study , risk factor , combination therapy , multiple drug resistance , cohort study , pseudomonas aeruginosa , methicillin resistant staphylococcus aureus , retrospective cohort study , antibiotics , intensive care medicine , staphylococcus aureus , microbiology and biotechnology , pathology , biology , bacteria , genetics , alternative medicine

Optimal empiric therapy for hospitalized patients with healthcare-associated pneumonia (HCAP) is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research